2027 Rare Cancer Conference, Los Angeles conference hero image

2027 Rare Cancer Conference, Los Angeles

Accreditation: 5.00 Nursing Contact Hours | 5.00 ABIM MOC II | 5.00 AMA PRA Category 1 Credit™ | 5.00 ACPE Pharmacy

Venue: The Westin Long Beach, 333 East Ocean Boulevard, Long Beach, CA, 90802, United States

Start Date:
Register for Conference

Official conference page for 2027 Rare Cancer Conference, Los Angeles.

About 2027 Rare Cancer Conference, Los Angeles

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Shivaani Kummar
6+

Faculty and committee

Conference program and agenda

Agenda

Friday, February 5th, 2027

All timings are in Pacific Time (PDT, GMT-07:00) time.

09:00 AM - 10:00 AMRegistration, Breakfast, & Exhibits
10:00 AM - 10:05 AMWelcome
10:05 AM - 10:20 AM Introduction by Dr. Shah or Binaytara Representative
10:20 AM - 10:40 AMSession 1: Case Study – Rare Cancer

Session Chair: Shivaani Kummar, MD, FACP

10:20 AM - 10:35 AM

Topic: Coming Soon....

10:35 AM - 10:40 AM

Q&A

10:40 AM - 11:00 AMSession 2: Case Study - Rare Subset of Common Cancer

Session Chair: Rajat Thawani, MD

10:40 AM - 10:55 AM

Topic: Coming Soon...

10:55 AM - 11:00 AM

Q&A

11:00 AM - 12:20 PMPanel Discussion - Sessions 1 & 2

Moderators:

Shivaani Kummar, MD, FACP; Rajat Thawani, MD

Panelist:

Amy Phillips

12:20 PM - 01:20 PM Lunch & Exhibits
01:20 PM - 01:50 PMPlenary: FDA Perspective on Rare Cancer Drug Development
01:50 PM - 02:50 PMSession 3: AYA & Pediatric-Relevant Rare Tumors (Sarcomas, AYA-Specific Rare Cancers)

Session Chair: Brandon Hayes-Lattin, MD, FACP

01:50 PM - 02:00 PM

Integration across Pediatric, AYA, and Adult Oncology – Noah Federman, MD

02:00 PM - 02:10 PM

Challenges in Accrual, Biology Differences, and Access

02:10 PM - 02:20 PM

Potential Spotlight on a Single Tumor Type

02:20 PM - 02:30 PM

NCI Experience and National Trial Networks

02:30 PM - 02:50 PM

Panel Discussion

Moderator:

Brandon Hayes-Lattin, MD, FACP

Panelist:

Alice Chen, MD

02:50 PM - 03:50 PM Session 4: Rare Subsets of Common Cancers (NTRK fusions in NSCLC, HER2-mutant lung cancer, ROS1/NTRK Outside Lung)

02:50 PM - 03:00 PM

Real-World Evidence to Inform Drug Development

03:00 PM - 03:10 PM

Pharma Role in Tissue-Agnostic and Ultra-Rare Subgroups

03:10 PM - 03:20 PM

Role of AI in Rare Cancers

03:20 PM - 03:50 PM

Panel Discussion

03:50 PM - 04:00 PMBreak & Exhibits
04:00 PM - 05:00 PMSession 5: Organizing Oncology Practices Around Rare Subsets Round Table Panel Discussion

04:00 PM - 04:15 PM

How to Triage “Rare within Common” Cases – Rajat Thawani, MD

04:15 PM - 04:25 PM

Designing Clinics/Virtual Programs for Rare Tumors – Nicholas Butowski, MD

04:25 PM - 04:35 PM

Billing, Coding, and Operational Considerations – John Hays, MD, PhD

04:35 PM - 04:45 PM

Community Partnerships for Low-Volume Diseases – Colin Barton, co-founder, DDS

04:45 PM - 04:55 PM

Role of Technology in Trial Accrual

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship